HEMK2
Methyltransferase HEMK2
Also known as: C21orf127, HEMK2_HUMAN, KMT9, MTQ2, N6AMT, N6AMT1, PRED28, PrmC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y5N5
- Gene
- HEMK2
- Ensembl
- ENSG00000156239
- Chromosome
- 21
- Canonical length
- 214 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Centrosome
OverviewNCBI Gene
This gene encodes an N(6)-adenine-specific DNA methyltransferase. The encoded enzyme may be involved in the methylation of release factor I during translation termination. This enzyme is also involved in converting the arsenic metabolite monomethylarsonous acid to the less toxic dimethylarsonic acid. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 11. [provided by RefSeq, Mar 2023]
Canonical amino-acid sequenceUniProt
214 residues, UniProt reviewed canonical sequence.
>Q9Y5N5|HEMK2
1 MAGENFATPF HGHVGRGAFS DVYEPAEDTF LLLDALEAAA AELAGVEICL EVGSGSGVVS
61 AFLASMIGPQ ALYMCTDINP EAAACTLETA RCNKVHIQPV ITDLVKGLLP RLTEKVDLLV
121 FNPPYVVTPP QEVGSHGIEA AWAGGRNGRE VMDRFFPLVP DLLSPRGLFY LVTIKENNPE
181 EILKIMKTKG LQGTTALSRQ AGQETLSVLK FTKSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HEMK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 7.8 nTPM
Expression across tissuesHPA
Tissue
- ovary: 7.8 nTPM
- retina: 7.8 nTPM
- cervix: 6.1 nTPM
- blood vessel: 6 nTPM
- placenta: 6 nTPM
- endometrium: 5.9 nTPM
Single-cell type
- tuft cells: 35 nCPM
- respiratory ciliated cells: 32 nCPM
- megakaryocytes: 31 nCPM
- thyrotrophs: 23 nCPM
- cytotrophoblasts: 22 nCPM
- oligodendrocytes: 21 nCPM
Immune cell
- naive CD4 T-cell: 1.4 nTPM
- NK-cell: 1.4 nTPM
- memory CD4 T-cell: 1 nTPM
- naive CD8 T-cell: 1 nTPM
- intermediate monocyte: 0.7 nTPM
- memory B-cell: 0.7 nTPM
Brain region
- white matter: 23 nTPM
- medulla oblongata: 18 nTPM
- pons: 17 nTPM
- basal ganglia: 17 nTPM
- hypothalamus: 17 nTPM
- cerebral cortex: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.68
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.42
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- arsonoacetate metabolic process
- methylation
- negative regulation of gene expression, epigenetic
- peptidyl-glutamine methylation
- positive regulation of cell growth
- toxin metabolic process
- transcription initiation-coupled chromatin remodeling
Molecular functions
- arsenite methyltransferase activity
- nucleic acid binding
- protein methyltransferase activity
- protein-glutamine N-methyltransferase activity
- S-adenosyl-L-methionine binding
- S-adenosylmethionine-dependent methyltransferase activity
- site-specific DNA-methyltransferase (adenine-specific) activity
- histone H4K12 methyltransferase activity
Cellular components
- cytosol
- nucleus
- protein-containing complex
- eRF1 methyltransferase complex
Protein domainsUniProt · Pfam · InterPro
- DNA methylase, N-6 adenine-specific, conserved site
- Methyltransferase small domain
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- Methyltransferase small domain
- Eukaryotic/archaeal PrmC-related
- Release factor glutamine methyltransferase Mtq2-like
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HEMK2 as an antibody target. Whether an autoantibody or antibody against HEMK2 could matter depends on whether native HEMK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HEMK2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HEMK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...